Article
Acute Myeloid Leukemia and Acute Promyelocytic Leukemia
1 Jan 2003
Abstract excerpt
The therapeutic approach to the patient with acute myeloid leukemia (AML) currently evolves toward new frontiers. This is particularly apparent from the entree of high-throughput diagnostic technologies and the identification of prognostic and therapeutic targets, the introduction of therapies in genetically defined subgroups of AML, as well as the influx of investigational approaches and novel drugs into the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
